Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates:: a factor for differing results of TPMT measurements

被引:25
作者
Kröplin, T
Fischer, C
Iven, H
机构
[1] Univ Lubeck, Dept Pharmacol, D-23538 Lubeck, Germany
[2] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany
关键词
thiopurine methyltransferase polymorphism;
D O I
10.1007/s002280050630
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives. Thiopurine S-methyltransferase (TPMT) activity, when measured in red blood cells (RBC) with a recently published TPMT activity assay using 6-thioguanine (6-TG) as substrate, could not be reproduced in another laboratory. We investigated factors which could influence the results of the TPMT activity measurement. Methods: We tested twelve 6-TG and four 6-mercaptopurine (6-MP) compounds from different suppliers as substrates and determined the enzyme kinetic parameters K-m and V-max. Furthermore, we studied the influence of different 6-TG compounds on the affinity of the methyl donor S-adenosyl-L-methionine (SAM) to the TPMT enzyme. Results: All 6-TG products were of equal purity (declared >98% by the supplier); this was ascertained by HPLC. However, the rate of methylation obtained following incubation with 6-TG from different suppliers ranged from 10% to 100% when incubated with the same RBC lysate. The lowest apparent K-m value for a 6-TG was 22.3 mu mol . l(-1), while the product with the highest methylation rate showed a K-m of 156 mu mol . l(-1) From these results we assume that there is a contaminant in some 6-TG products, which acts as a strong inhibitor of TPMT activity. Compounds possibly used for the synthesis of 6-TG (guanine, pyridine, 6-chloroguanine) did not affect the methylation rate. Thioxanthine, which is known to be a strong inhibitor of TPMT when added to the assay system to give a 2% contamination, reduced TPMT activity from 100% to 72%. Using 6-MP from different suppliers as substrate resuited in K-m values ranging from 110 to 162 mu mol . l(-1) and V-max values ranging from 54 to 68 nmol 6-MMP . g(-1) Hb . h(-1). The K-m value for the methyl donor SAM was similar to and independent from the thiopurine substrates tested (range 4.9-11 mu mol . l(-1) SAM). In contrast to other investigators, we found nonenzymatic S-methylation, which was negligible under our assay conditions (3% with 128 mu mol . l(-1) SAM), but could become relevant in experiments using higher SAM concentrations. Conclusions: TPMT enzyme activity determined with 6-TG as substrate may be strongly inhibited by a contaminant in some of the 6-TG lots distributed.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 23 条
[1]   THE IMPORTANCE OF THIOPURINE METHYLTRANSFERASE ACTIVITY FOR THE USE OF AZATHIOPRINE IN TRANSPLANT RECIPIENTS [J].
CHOCAIR, PR ;
DULEY, JA ;
SIMMONDS, HA ;
CAMERON, JS .
TRANSPLANTATION, 1992, 53 (05) :1051-1056
[2]   SIMPLE GRAPHICAL METHOD FOR DETERMINING INHIBITION CONSTANTS OF MIXED, UNCOMPETITIVE AND NON-COMPETITIVE INHIBITORS [J].
CORNISHB.A .
BIOCHEMICAL JOURNAL, 1974, 137 (01) :143-144
[3]  
CORNISHBOWDEN A, 1986, FEBS LETT, V203, P3, DOI 10.1016/0014-5793(86)81424-7
[4]   PURINE SUBSTRATES FOR HUMAN THIOPURINE METHYLTRANSFERASE [J].
DEININGER, M ;
SZUMLANSKI, CL ;
OTTERNESS, DM ;
VANLOON, J ;
FERBER, W ;
WEINSHILBOUM, RM .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (11) :2135-2138
[5]   THE DETERMINATION OF ENZYME INHIBITOR CONSTANTS [J].
DIXON, M .
BIOCHEMICAL JOURNAL, 1953, 55 (01) :170-171
[6]   THE SYNTHESIS OF 6-THIOGUANINE [J].
ELION, GB ;
HITCHINGS, GH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1955, 77 (06) :1676-1676
[7]  
JACQZAIGRAIN E, 1994, BRIT J CLIN PHARMACO, V38, P1
[8]   THIOPURINE METHYLTRANSFERASE ACTIVITY IN A SAMPLE-POPULATION OF BLACK SUBJECTS IN FLORIDA [J].
JONES, CD ;
SMART, C ;
TITUS, A ;
BLYDEN, G ;
DORVIL, M ;
NWADIKE, N .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :348-353
[9]   IDENTIFICATION OF FACTORS REGULATING THIOPURINE METHYLTRANSFERASE ACTIVITY IN A NORWEGIAN POPULATION [J].
KLEMETSDAL, B ;
STRAUME, B ;
WIST, E ;
AARBAKKE, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (02) :147-152
[10]   INTERETHNIC DIFFERENCE IN THIOPURINE METHYLTRANSFERASE ACTIVITY [J].
KLEMETSDAL, B ;
TOLLEFSEN, E ;
LOENNECHEN, T ;
JOHNSEN, K ;
UTSI, E ;
GISHOLT, K ;
WIST, E ;
AARBAKKE, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) :24-31